Sirolimus-tacrolimus combination for combined kidney-pancreas transplantation: effect on renal function.
Multi-Organ Transplant Program, Dalhousie University Queen Elizabeth II Health Sciences Centre, Halifax, Nova Scotia, Canada.
A
A
Salazar
V C
VC
McAlister
B A
BA
Kiberd
H
H
Bitter-Suermann
M F
MF
Al-Kerithy
A S
AS
MacDonald
D000328:Adult; D003131:Combined Modality Therapy; D003922:Diabetes Mellitus, Type 1 / Q000601:surgery; D003928:Diabetic Nephropathies / Q000601:surgery; D005500:Follow-Up Studies; D006085:Graft Survival; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D007668:Kidney / Q000187:drug effects* / Q000502:physiology; D007676:Kidney Failure, Chronic / Q000601:surgery; D016030:Kidney Transplantation / Q000276:immunology* / Q000502:physiology; D016035:Pancreas Transplantation / Q000276:immunology*; D020123:Sirolimus / Q000627:therapeutic use*; D016559:Tacrolimus / Q000627:therapeutic use*
D007166:Immunosuppressive Agents; D020123:Sirolimus; D016559:Tacrolimus